Third, to examine if this effect is due to IDH1 mutations, they created isogenic IDH‐wildtype and IDH‐mutant mouse glioma models whose initiating events were identical except for the expression of IDH1 mutation. The gene discussed is IDH2; the disease is central nervous system cancer.